Header Supplemental Questions to Malignant Peripheral Blood and Bone Marrow Review Mark D. Fleming, M.D., D.Phil. Subhead.

Slides:



Advertisements
Similar presentations
Hematopathology Lab December 12, Case 1 . Normal Peripheral Blood Smear.
Advertisements

TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
A Hematology Case Study about Leukemia by Sarah Wycoff
Leukemia Leukemia is a general term for a group of malignancies of either lymphoid or hematopoietic cell origin.
Introduction To Haematological Malignancies
LEUKEMIA—HEMATOLOGY {S1}
Leukemias.
Identification and Diagnosis of the Acute Leukemias
LEUKEMIAS Dr Mehboob Khan Pathologist
Acute leukemia Aggressive malignant hematopoietic disorders
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Tabuk University Faculty of Applied Medical Sciences
Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.
Acute Myeloid Leukemias (AML)
Oncology Slide Review LaJuan Chambers, MD. 16 yo young man with fatigue, pallor and low-grade fever for 2 weeks On exam, spleen palpated 8cm below left.
Jan Żeromski Pathology 2010/2011.  Malignant proliferation of white cells of the hematopoietic system with infestation of blood and usually bone marrow.
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Morphology Review - ISH Slides - 제 2 차 혈액학 종합학술대회 발표 2000 년 5 월 25 일 -5 월 26 일 COEX 한림의대 조 현 찬.
ICCS e-Newsletter CSI Fall 2010 David D. Grier, M.D. Department of Pathology. Wake Forest University.
4th Year Medical Student KAU
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
CHRONIC LEUKEMIA Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
MLAB 1415: Hematology Keri Brophy-Martinez
Acute Leukemia Kristine Krafts, M.D..
Case 251: Clinical Information Raymond E Felgar, MD, PhD University of Pittsburgh, Pittsburgh, PA 45-year-old man with recent history of shingles, night.
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Acute lymphoblastic leukemia in children
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
Hematology There are four lectures: 1.Acute leukemias (2 hours). 2.Chronic leukemias (2 hours).
Society for Hematopathology/European Association for Haematopathology 2013 Case Number 208 Erika Moore, MD; Darshan Roy, MD; Patti Cohen, MD; Adam Bagg,
Case 316 Ryan Johnson, MD; Athena Cherry, PhD; Dita Gratzinger, MD, PhD Stanford University Medical Center SH-EAHP October 24, 2013.
CASE 411 Jose Gonzalez-Berjon, MD & Tariq Muzzafar, MD UT M.D. Anderson Cancer Center.
Peripheral Blood, Bone Marrow, and Tissue Morphology: Neoplastic Hematology Charles Timmons, MD, PhD UT Southwestern Medical Center at Dallas Dallas, Texas.
Associate professor of Internal Medicine
Acute Leukemia Kristine Krafts, M.D..
CASE OF THE MONTH Dr Narender Tejwani Consultant ( Hematopathologist)
Malignancies of hematopoietic cells. Leukemia
Session 7, case 171 Extramedullary Manifestations of Myeloid Neoplasms
CASE SUBMISSION 2016 EAHP BM Workshop
Acute myeloid leukemia
Acute Myeloid Leukemia
LEUKEMIAS H.A. MWAKYOMA, MD.
CLINICAL PROGRESSION INTRODUCTION METHOD CONCLUSION REFERENCES
Cells Maturation in Bone Marrow.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
11 th lecture Chronic myeloid leukaemia By DR Fatehia Awny Faculty of Health Science Beirut Arab University
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Early T-Cell Precursor ALL in 5 Year Old Female
Associate professor of Internal Medicine
Leukemia Case 1.
Acute Myeloid Leukemia
Case Study ….
Case:2 leukemia دينا نعمان جرادة جيهان ايمن مقاط.
Acute leukemia.
LEUKEMIA CASE STUDY 2.
Diagnostic Hematology
PATHOLOGY PRACTICALS-II LEUKEMIAS & MULTIPLE MYELOMA
بسم الله الرحمن الرحيم Acute lymphoid leukemia(ALL) Prepared by ::
A presentation By Abedelaziz Taha Hammash supervisor \ Mr
Leukemia case (18).
Acute Leukemia Dr. Noha Noufal.
Chronic Leukemia Dr. Noha Noufal.
Case study 14 Hadeel , Huda , Abeer.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
LEUKEMIA CASE.
Presentation transcript:

Header Supplemental Questions to Malignant Peripheral Blood and Bone Marrow Review Mark D. Fleming, M.D., D.Phil. Subhead

Hx: 16 yo boy with pallor and bruising Hx: 16 yo boy with pallor and bruising. Blood smear shows anemia, thrombocytopenia, leukocytosis (100,000/mm3, 90% immature cells). Flow cytometry on blood shows cells are TdT+, CD10+, CD3+, CD7+, CD4+, and CD8+. AML B-cell ALL T-cell ALL Hematogones Mononucleosis

AML B-cell ALL T-cell ALL Hematogone hyperplasia Mononucleosis Comment: The cells are T lymphoblasts by morphology and flow cytometry. The atypical lymphs in mononucleosis are T cells, but are larger and have abundant cytoplasm often with scant cytotoxic granules and are mostly CD8 bright positive Hematogones are rarely seen in peripheral blood. Very high white count, male sex and age, even in the absence of a mediastinal mass, should make one think about T-cell ALL

Hx: 6 yo boy with bone pain Hx: 6 yo boy with bone pain. Blood smear shows pancytopenia, and 5% circulating immature cells (pictured). Flow cytometry on marrow shows 80% cells are TdT+, CD10+, CD19+, CD20-. AML B-cell ALL T-cell ALL Hematogones Mononucleosis

AML B-cell ALL T-cell ALL Hematogones Mononucleosis Comment: These cells are morphologically lymphoid and have an immature B phenotype by flow cytometry. Hematogones should show more of a spectrum of maturation and are unlikely to completely replace the normal marrow elements. Burkitt leukemia (BL) is certainly in the differential, particularly given the vacuolization of the cells. The immunophenotype is supportive of BL other than the TdT positivity and lack of CD20 expression. Clonal surface immunoglobulin staining and a MYC translocation by cytogenetics/FISH would also be present in BL

Hx: 7 yo boy with an recent onset of vomiting and lethargy Hx: 7 yo boy with an recent onset of vomiting and lethargy. Blood smear shows increased neutrophils with a left shift and 8% abnormal cells. Bone marrow contains 60% of the same cells. Flow cytometry shows that the cells are TdT-, CD10+, CD19+, CD20+, sIg+. Burkitt L/L B-cell ALL T-cell ALL Hematogones DLBCL

Burkitt L/L B-cell ALL T-cell ALL Hematogones DLBCL Comment: Flow cytometry shows mature CD10+ B-cells, and the morphology is that of Burkitt lymphoma, which occasionally can have a leukemic phase. DLBCL is certainly a consideration, but a truly leukemic phase (rather than just marrow involvement), would be really unusual. A MYC rearrangement by cytogenetics/FISH would also be diagnostically helpful.

Hx: 13 yo boy with fatigue, weight loss, night sweats and splenomegaly Hx: 13 yo boy with fatigue, weight loss, night sweats and splenomegaly. Peripheral blood shows anemia, thrombocytosis and leukocytosis (300,000/mm3). Leukemoid Reaction ALL CML JMML AML

Leukemoid Reaction ALL CML JMML AML Comment: A neutrophilic leukocytosis and a left shift with a basophilia and thrombocytosis without increased blasts are typical of chronic phase of CML. Cytogenetics/FISH showing t(9;22)(q34;q11.2) would be diagnostic. Leukemoid reaction is also in the differential, but basophilia and an absence of monocytosis would be a bit unusual. JMML is a disease of much younger children (typically <4, certainly <8) and nearly always is associated with thrombocytopenia.

Hx: 2 yo girl with new onset of fever and bronchitis Hx: 2 yo girl with new onset of fever and bronchitis. Has maculo-papular rash and hepatosplenomegaly. Blood smear has leukocytosis (100,000/mm3), anemia and thrombocytopenia. Ancillary tests include fetal hemoglobin of 80% and normal blood karyotype. Leukemoid Reaction ALL CML JMML AML

Leukemoid Reaction ALL CML JMML AML Comment: Marked leukocytosis including monocytosis without increased blasts or a basophilia are typical. As are trombocytopenia and anemia often accompanied by erythroblastosis. Elevation of fetal hemoglobin is characteristic of JMML. Cytogenetics are typically normal and a BCR/ABL1 fusion is not present. Somatic mutations in the RAS signaling pathway are common.

Hx: 1 yo boy with pallor and a rash Hx: 1 yo boy with pallor and a rash. Blood smear shows pancytopenia and circulating abnormal cells. AML CML JMML ALL LGL leukemia

AML CML JMML ALL LGL leukemia Comment: The large blasts with ample cytoplasm and prominent nucleoli are suggestive of AML, but the Auer rod is diagnostic of AML!

Hx: 8 yo boy with bruising Hx: 8 yo boy with bruising. Blood smear shows anemia, thrombocytopenia, and leukocytosis (30,000/mm3, 50% blasts). Flow cytometry on marrow shows 50% blasts with TdT+, MPO+, CD13+, CD33+, partial CD19+. AML CML ALL MDS LGL Leukemia

AML CML ALL MDS LGL Leukemia Comment: Morphology shows dysplastic myeloid maturation, blasts with “salmon pink granules,” and a large Auer rods. Flow cytometry shows a myeloid phenotype with coexpression of CD19 and TdT. Although this is a “mixed” myeloid and B lymphoid phenotype (? Mixed Phenotype Acute Leukemia/MPAL) this constellation of findings is highly associated with with t(8;21)(q22;q22) and RUNX1/RUNX1T1 fusion (i.e., AML with a recurrent cytogenetic abnormality) and is defined as such as AML regardless of the phenotype or blast count.

Hx: 8 yo girl with fever and palpable, non-painful macular skin lesions. Blood smear shows anemia, thrombocytopenia, and leukocytosis (140,000/mm3, 60% blasts). Auer rod are not present. Flow cytometry shows 60% blasts that are CD34+, CD13+, CD33+, CD64+, CD11b+/-, MPO-/+. Chediak-Higashi Basophilic Leukemia AML, M4Eo APML ALL

Chediak-Higashi Basophilic Leukemia AML, M4Eo APML ALL Comment: The blasts have a monocytic morphology a a myelomonocytic phenotype, so this is AML. The strange, darkly granulated cells are abnormal eosinophils—“Eo-Basos”—a morphology that correlates with a karyotype of inv(16) or t(16;16).

Hx: 13 yo girl with fever and swelling of one leg Hx: 13 yo girl with fever and swelling of one leg. Blood smear shows anemia and thrombo-cytopenia. WBC 3400/mm3 with marked left shift. Marrow has 82% immature myeloid cells as shown. Flow cytometry on marrow shows MPO+, CD33+, CD13 partial+, HLA-DR-, CD34-. Toxic maturation arrest APML CML Mast cell leukemia Technical artifact

Toxic maturation arrest APML CML Mast cell leukemia Technical artifact Comment: Atypical promyelocytes, which may have multiple Auer rods, rather than blasts characterize acute promyelocytic leukemia (APML), which is associated with t(15;17) and a PML/RARA fusion. These “blast equivalents” are typically HLA-DR and CD34 negative

Hx: 19 yo girl with history of treatment for ALCL 2 years prior Hx: 19 yo girl with history of treatment for ALCL 2 years prior. Now with persistent pancytopenia (WBC 800/mm3, no circulating blasts). Marrow has 80% abnormal cells that by flow cytometry are MPO-, CD33+, CD34-, CD13+, CD11b+, CD14+. Relapsed ALCL JMML ALL de novo AML Therapy-related AML

Relapsed ALCL JMML ALL De novo AML Therapy-related AML Comment: The morphology and flow cytometry are those of monoblasts, which is characteristic of therapy-related AML, especially with rearrangements of the MLL gene at chromosome 11q23.

Hx: 1 yo boy with fever and weight loss Hx: 1 yo boy with fever and weight loss. Blood shows anemia and neutropenia with 5% circulating blasts. Marrow has 95% abnormal cells that by flow cytometry are MPO-, CD33+, CD34-, HLA-DR-, CD41+, CD61+. AML AMkL TAM Neuroblastoma Medulloblastoma

AML AMkL TAM Neuroblastoma Medulloblastoma Comment: The immunophenotype and marrow replacement indicate the megakaryoblastic variant of AML. Megakaryoblasts may be small, resembling lymphoblasts. Platelet-like cytoplasmic buds are common, but not specific.

Hx: 6 mo girl with a large abdominal mass and elevated serum catecholamines. Bone marrow aspirations contains the cells pictured. Flow cytometry shows the cells to be CD56+. AML/myeloid sarcoma Metastatic Wilms tumor Osteoblasts NK cell leukemia/lymphoma Metastatic neuroblastoma

AML/myeloid sarcoma Metastatic Wilms tumor Osteoblasts NK cell leukemia/lymphoma Metastatic neuroblastoma Comment: Clumps of small cells are most likely solid tumor. CD56 not only marks natural killer cells but is also a neural cell adhesion molecule. “Small” cells, sometimes associated with pink fibrillary neuropil in the clinical context of elevated catecholamines is characteristic of neuroblastoma. Clumps of osteoblasts, which are common in aspirates from children, can be mistaken for metastatic tumor